Pandemic Timeline

Patent US11107588: Methods and systems of prioritizing treatments, vaccination, testing and/or activities while protecting the privacy of individuals

Note the little lightening bolts next to the head.

This Pfizer patent application was approved August 31st, 2021, and is the very first patent that shows up in a list of over 18500 for the purpose of remote contact tracing of all vaccinated humans worldwide who will be or are now connected to the “internet of things” by a quantum link of pulsating microwave frequencies of 2.4 gHz or higher from cell towers and satellites directly to the graphene oxide held in the fatty tissues of all persons who’ve had the death-shot.

Phil Stone

System and methods for anonymously selecting subjects for treatment against an infectious disease caused by a pathogen. The system comprises a plurality of electronic devices comprising instructions to generate an ID and, when in proximity of another such electronic device, one or both electronic devices transmit/receive the ID to/from the other electronic device. Then, a score is generated based on a plurality of such received IDs. Additionally, based on information received from a server, relevant treatment instructions are displayed to the subjects based on the received information and the score. The server comprises instructions for sending to the plurality of electronic devices the information to be displayed with the relevant treatment instructions, additionally the server and/or the electronic devices comprise instructions to generate a prediction of likelihood of a subject transmitting the pathogen, based on the score of the subject.

Patent US11107588B2

This patent is about contact tracing and scoring people’s health. Gal Ehrlich and Maier Fenster are patent attorneys.  From their site:

Among the clients working with Ehrlich & Fenster (E&F) are major international corporations including Microsoft, IBM, Samsung, Huawei, Monsanto, Plasson, Playtech Software, as well as world renowned universities, medical and research institutes, such as Yeda Research and Development at the Weizmann Institute of Science, Yissum at the Hebrew University of Jerusalem and the Technion Research & Development Foundation, and joint ventures formed by international and Israeli major players, countless startups, top researchers, developers and inventors in Israel and abroad, some of which are Nobel Prize and Wolf Prize laureates. Further among our clients are patent attorneys from Europe and the Far East who use our services for National Stage filing and prosecution, not only in Israel, but also extensively in the United States.

Ehrlich & Fenster

Note that Microsoft and IBM top their list of clients.  We do not know from the patent exactly for whom they filed it, but we have a major clue.  Drawings in the patent look like those in patents by Richard Rothschild.
Dr. Robert Young believes that this patent may be in use in the COVID-19 vaccines.  Karen Kinston does not believe that the manufacturers had time to fully activate the initial batches, but future batches may be activated.

Patent 11107588, page 43, column 52, line 10

Patent 11107588, page 43, column 52, line 46

Australia has implemented this technology as the G2G Now app.

Patent 11107588, page 30, column 28, line 28

This is the WHO link mentioned in the above clip from the patent.

Why Was This Technology Developed?

Clay Clark video description

Sources:

Related:

See also, on this site:

Comments are closed.